Pulmonx (LUNG) Capital Expenditures Growth (3y) (2022 - 2025)
Pulmonx (LUNG) Capital Expenditures Growth (3y) (2022 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.20 Bn | 175.91 Bn | 6.27 Bn | 1.64% |
| 2 | Stryker | 128.87 Bn | 125.99 Bn | 3.81 Bn | 8.49% |
| 3 | Medtronic | 108.88 Bn | 99.66 Bn | 6.41 Bn | 8.89% |
| 4 | Boston Scientific | 68.33 Bn | 66.87 Bn | 3.61 Bn | 16.83% |
| 5 | Edwards Lifesciences | 47.31 Bn | 43.64 Bn | 1.29 Bn | 1.81% |
| 6 | Dexcom | 28.65 Bn | 27.53 Bn | 750.30 Mn | 0.84% |
| 7 | GE HealthCare Technologies | 28.40 Bn | 26.11 Bn | 1.98 Bn | 7.57% |
| 8 | Smith & Nephew | 26.97 Bn | 26.40 Bn | - | - |
| 9 | Koninklijke Philips | 25.55 Bn | 22.42 Bn | 2.07 Bn | 2.15% |
| 10 | Pulmonx | 49.12 Mn | -20.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -48.03% |
| Jun 30, 2025 | -42.11% |
| Mar 31, 2025 | -18.89% |
| Dec 31, 2024 | -64.06% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 2.61% |
| Mar 31, 2024 | -11.45% |
| Dec 31, 2023 | -57.82% |
| Sep 30, 2023 | -27.48% |
| Jun 30, 2023 | -57.69% |
| Mar 31, 2023 | 59.37% |
| Dec 31, 2022 | -12.62% |